SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 648.22 |
Enterprise Value ($M) | 283.33 |
Book Value ($M) | 533.09 |
Book Value / Share | 27.97 |
Price / Book | 1.22 |
NCAV ($M) | 312.97 |
NCAV / Share | 16.42 |
Price / NCAV | 2.07 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.10 |
Return on Assets (ROA) | 0.09 |
Return on Equity (ROE) | 0.11 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.37 |
Current Ratio | 3.93 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 451.19 |
Assets | 671.31 |
Liabilities | 138.22 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Renaissance Technologies Llc | 6.27 | -2.15 | |
13G/A | Vanguard Group Inc | 8.27 | 3.12 | |
13G/A | BlackRock, Inc. | 9.60 | -6.48 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
12,265 | 75,335 | 16.28 | |
10,564 | 78,920 | 13.39 | |
20,693 | 104,415 | 19.82 | |
(click for more detail) |
Similar Companies | |
---|---|
QGEN – Qiagen N.V. | RCUS – Arcus Biosciences, Inc. |
RFL – Rafael Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io